No valuation score is currently available for Spruce Biosciences Inc. The Biotechnology & Medical Research industry's average is 7.83. Its current P/E ratio is -1.47, which is -99.75% below the recent high of -0.00 and -12.29% above the recent low of -1.65.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.